Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

A new international study led by scientists from Ben-Gurion University of the Negev has characterized the populations of fat ...

Healthpoint to offer advanced therapies for lipedema and lymphedema via a dedicated multidisciplinary team, ensuring comprehensive treatment within a single multidisciplinary clinic The medical team ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales ...

Over the past decades, obesity has reached epidemic proportions, now affecting more than 1 billion people worldwide. Childhood obesity, in particular, is rising at an alarming rate. According to ...

Rani Therapeutics Holdings , Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company with a market capitalization of $48.3 million, today announced promising results from a preclinical study on ...

According to Talat Imran, CEO of Rani Therapeutics, these findings validate the potential of the RaniPill® platform to deliver a variety of injectable obesity treatments orally. The company ...

The new atlas shows the types of cells in fat tissue and their functions but doesn’t clarify if the differences cause ...

Scientists have created the most detailed map to date of the human hypothalamus ... an invaluable resource for scientists worldwide. By offering insights into the hypothalamus's role in conditions ...

New research from the University of Delaware aims to tackle the issue by investigating obesity at the gene level. Principal investigator Ibra Fancher, assistant professor of kinesiology and applied ...